New Light-Based scanner aims to spot inflammation without needles

NCT ID NCT05333978

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new imaging tool called multispectral optoacoustic tomography (MSOT) to see if it could safely detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. The device uses light and sound to create images of inflamed areas. The trial was terminated early, but it collected safety data from 29 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MSOT Device
What this could lead to
If successful, this could provide a non-invasive way to detect inflammation in conditions like GVHD, Crohn's, and colitis, potentially reducing the need for biopsies.
What could go wrong
The trial was terminated early with only 29 participants, so results are limited. The device is experimental and not yet proven to be effective for diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE OF THE SKIN OR GI TRACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Oklahoma Health Sciences Center, Stephenson Cancer Center

    Oklahoma City, Oklahoma, 73014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.